Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo.

Carroll SH, Wigner NA, Kulkarni N, Johnston-Cox H, Gerstenfeld LC, Ravid K.

J Biol Chem. 2012 May 4;287(19):15718-27. doi: 10.1074/jbc.M112.344994. Epub 2012 Mar 8.

2.

EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair.

Zhang M, Ho HC, Sheu TJ, Breyer MD, Flick LM, Jonason JH, Awad HA, Schwarz EM, O'Keefe RJ.

J Bone Miner Res. 2011 Apr;26(4):792-802. doi: 10.1002/jbmr.272.

3.

Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.

Bäckesjö CM, Li Y, Lindgren U, Haldosén LA.

J Bone Miner Res. 2006 Jul;21(7):993-1002.

4.

Osteogenesis Is Improved by Low Tumor Necrosis Factor Alpha Concentration through the Modulation of Gs-Coupled Receptor Signals.

Daniele S, Natali L, Giacomelli C, Campiglia P, Novellino E, Martini C, Trincavelli ML.

Mol Cell Biol. 2017 Mar 31;37(8). pii: e00442-16. doi: 10.1128/MCB.00442-16. Print 2017 Apr 15.

PMID:
28137910
5.

Myocilin stimulates osteogenic differentiation of mesenchymal stem cells through mitogen-activated protein kinase signaling.

Kwon HS, Johnson TV, Tomarev SI.

J Biol Chem. 2013 Jun 7;288(23):16882-94. doi: 10.1074/jbc.M112.422972. Epub 2013 Apr 29.

6.

Cilomilast enhances osteoblast differentiation of mesenchymal stem cells and bone formation induced by bone morphogenetic protein 2.

Munisso MC, Kang JH, Tsurufuji M, Yamaoka T.

Biochimie. 2012 Nov;94(11):2360-5. doi: 10.1016/j.biochi.2012.05.031. Epub 2012 Jun 15.

PMID:
22706281
7.

Deficiency of adiponectin protects against ovariectomy-induced osteoporosis in mice.

Wang F, Wang PX, Wu XL, Dang SY, Chen Y, Ni YY, Gao LH, Lu SY, Kuang Y, Huang L, Fei J, Wang ZG, Pang XF.

PLoS One. 2013 Jul 2;8(7):e68497. doi: 10.1371/journal.pone.0068497. Print 2013.

8.

Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1.

Zhao L, Huang J, Zhang H, Wang Y, Matesic LE, Takahata M, Awad H, Chen D, Xing L.

Stem Cells. 2011 Oct;29(10):1601-10. doi: 10.1002/stem.703.

9.

Prunetin signals via G-protein-coupled receptor, GPR30(GPER1): Stimulation of adenylyl cyclase and cAMP-mediated activation of MAPK signaling induces Runx2 expression in osteoblasts to promote bone regeneration.

Khan K, Pal S, Yadav M, Maurya R, Trivedi AK, Sanyal S, Chattopadhyay N.

J Nutr Biochem. 2015 Dec;26(12):1491-501. doi: 10.1016/j.jnutbio.2015.07.021. Epub 2015 Aug 8.

PMID:
26345541
10.

Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.

Mahalingam CD, Datta T, Patil RV, Kreider J, Bonfil RD, Kirkwood KL, Goldstein SA, Abou-Samra AB, Datta NS.

J Endocrinol. 2011 Nov;211(2):145-56. doi: 10.1530/JOE-11-0144. Epub 2011 Aug 18.

11.

Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.

Sharff KA, Song WX, Luo X, Tang N, Luo J, Chen J, Bi Y, He BC, Huang J, Li X, Jiang W, Zhu GH, Su Y, He Y, Shen J, Wang Y, Chen L, Zuo GW, Liu B, Pan X, Reid RR, Luu HH, Haydon RC, He TC.

J Biol Chem. 2009 Jan 2;284(1):649-59. doi: 10.1074/jbc.M806389200. Epub 2008 Nov 5.

12.

Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ).

Zhang W, Yang N, Shi XM.

J Biol Chem. 2008 Feb 22;283(8):4723-9. Epub 2007 Dec 14.

13.

Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells.

Disthabanchong S, Radinahamed P, Stitchantrakul W, Hongeng S, Rajatanavin R.

Kidney Int. 2007 Feb;71(3):201-9. Epub 2006 Dec 20.

14.

FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.

Hamidouche Z, Haÿ E, Vaudin P, Charbord P, Schüle R, Marie PJ, Fromigué O.

FASEB J. 2008 Nov;22(11):3813-22. doi: 10.1096/fj.08-106302. Epub 2008 Jul 24.

PMID:
18653765
15.

Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells.

Huang H, Zhao N, Xu X, Xu Y, Li S, Zhang J, Yang P.

Cell Prolif. 2011 Oct;44(5):420-7. doi: 10.1111/j.1365-2184.2011.00769.x.

PMID:
21951285
16.

Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.

Sanvoranart T, Supokawej A, Kheolamai P, U-Pratya Y, Klincumhom N, Manochantr S, Wattanapanitch M, Issaragrisil S.

Biochem Biophys Res Commun. 2014 May 16;447(4):580-5. doi: 10.1016/j.bbrc.2014.04.044. Epub 2014 Apr 18.

PMID:
24747566
17.

Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line.

Su SJ, Chang KL, Su SH, Yeh YT, Shyu HW, Chen KM.

Int J Food Sci Nutr. 2013 Jun;64(4):429-36. doi: 10.3109/09637486.2012.759184. Epub 2013 Jan 9.

PMID:
23301724
18.

Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway.

Sonomoto K, Yamaoka K, Oshita K, Fukuyo S, Zhang X, Nakano K, Okada Y, Tanaka Y.

Arthritis Rheum. 2012 Oct;64(10):3355-63. doi: 10.1002/art.34555.

19.

Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis.

Duque G, Huang DC, Macoritto M, Rivas D, Yang XF, Ste-Marie LG, Kremer R.

Stem Cells. 2009 Mar;27(3):550-8. doi: 10.1634/stemcells.2008-0886.

20.

Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.

van der Horst G, Farih-Sips H, Löwik CW, Karperien M.

J Bone Miner Res. 2005 Dec;20(12):2233-44. Epub 2005 Aug 29.

Supplemental Content

Support Center